Anti-obesogenic and antidiabetic effects of plants and mushrooms. (Q30241950)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27636731%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

review article

1 reference

title

Anti-obesogenic and antidiabetic effects of plants and mushrooms (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27636731%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27636731%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27636731%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27636731%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Chih-Jung Chang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27636731%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Chuan-Sheng Lin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27636731%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Chia-Chen Lu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27636731%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Yun-Fei Ko

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27636731%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Shun-Fu Tseng

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27636731%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

John D Young

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27636731%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

publication date

16 September 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27636731%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Endocrinology

23 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27636731%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27636731%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27636731%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

page(s)

149-160

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27636731%20AND%20SRC:MED&resulttype=core&format=json

The Global Epidemic of Obesity: An Overview

23 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

The public health impact of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

The medical risks of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Obesity and health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Genetics of obesity and the prediction of risk for health

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

From obesity genetics to the future of personalized obesity therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Pharmacologic treatment options for obesity: what is old is new again

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Long-term drug treatment for obesity: a systematic and clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Current status of the field of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Orlistat-associated adverse effects and drug interactions: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Obesity treatment: novel peripheral targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Phytochemicals and adipogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Dietary phytochemicals and their potential effects on obesity: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

A systematic review on use of Chinese medicine and acupuncture for treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Natural products and drug discovery. Can thousands of years of ancient medical knowledge lead us to new and powerful drug combinations in the fight against cancer and dementia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Historical review of medicinal plants' usage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Natural products as sources of new drugs over the period 1981-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

The evolving role of natural products in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

The value of plants used in traditional medicine for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Health effects of vegan diets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Making claims: functional foods for managing appetite and weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Artemisinin, a miracle of traditional Chinese medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

The pharmacological potential of mushrooms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Mushroom immunomodulators: unique molecules with unlimited applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Medicinal mushroom science: Current perspectives, advances, evidences, and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Treatment of obesity with celastrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Brain regulation of appetite and satiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Bowels control brain: gut hormones and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Brain regulation of energy balance and body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Endoplasmic reticulum stress plays a central role in development of leptin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Mechanisms of leptin action and leptin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Unfolded protein response signaling and metabolic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Effect of fenugreek fiber on satiety, blood glucose and insulin response and energy intake in obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Pancreatic lipase inhibitors from natural sources: unexplored potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Maté tea inhibits in vitro pancreatic lipase activity and has hypolipidemic effect on high-fat diet-induced obese mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Screening for anti-lipase properties of 37 traditional Chinese medicinal herbs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

The amylase inhibitor montbretin A reveals a new glycosidase inhibition motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Drug-nutrient interactions: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Dose effects of dietary phytosterols on cholesterol metabolism: a controlled feeding study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

A mouse model of diet-induced obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Brown adipose tissue in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Endocrine functions of adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Inhibitory effect of (-)-epigallocatechin-3-gallate on lipid accumulation of 3T3-L1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Green tea polyphenol epigallocatechin gallate inhibits adipogenesis and induces apoptosis in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Enhanced inhibition of adipogenesis and induction of apoptosis in 3T3-L1 adipocytes with combinations of resveratrol and quercetin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Genistein affects adipose tissue deposition in a dose-dependent and gender-specific manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Genistein inhibits differentiation of primary human adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Active ingredients from natural botanicals in the treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Effects of capsaicin on induction of apoptosis and inhibition of adipogenesis in 3T3-L1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

PPARgamma in adipocyte differentiation and metabolism--novel insights from genome-wide studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Wild ginseng prevents the onset of high-fat diet induced hyperglycemia and obesity in ICR mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Adiponectin: a relevant player in PPARgamma-agonist-mediated improvements in hepatic insulin sensitivity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Thiazolidinediones and PPARγ agonists: time for a reassessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Brown fat in humans: turning up the heat on obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Uncoupling protein-3 is a mediator of thermogenesis regulated by thyroid hormone, beta3-adrenergic agonists, and leptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Food Ingredients as Anti-Obesity Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Uncoupled protein 3 and p38 signal pathways are involved in anti-obesity activity of Solanum tuberosum L. cv. Bora Valley

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

AMPK: a key regulator of energy balance in the single cell and the whole organism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

AMPK: a nutrient and energy sensor that maintains energy homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Resveratrol induces brown-like adipocyte formation in white fat through activation of AMP-activated protein kinase (AMPK) α1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Comparative study of contents of several bioactive components in fruiting bodies and mycelia of culinary-medicinal mushrooms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Exposure assessment of lovastatin in Pu-erh tea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Epigallocatechin-3-gallate potently inhibits the in vitro activity of hydroxy-3-methyl-glutaryl-CoA reductase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Flavonoids protect against cytokine-induced pancreatic beta-cell damage through suppression of nuclear factor kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Role of oxidative stress in pancreatic beta-cell dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Antioxidant activity and protecting health effects of common medicinal plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Antidiabetic properties of dietary flavonoids: a cellular mechanism review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Effects of green tea extract on insulin resistance and glucagon-like peptide 1 in patients with type 2 diabetes and lipid abnormalities: a randomized, double-blinded, and placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Low molecular weight chitosan accelerates glucagon-like peptide-1 secretion in human intestinal endocrine cells via a p38-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Anti-diabetic effect of cinnamon extract on blood glucose in db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Konjac-Mannan and American ginsing: emerging alternative therapies for type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Impact of the gut microbiota, prebiotics, and probiotics on human health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Targeting gut microbiota in obesity: effects of prebiotics and probiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

The gut microbiota, obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

An obesity-associated gut microbiome with increased capacity for energy harvest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Gut microbiota: Ganoderma lucidum, a new prebiotic agent to treat obesity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Glucagon-like peptide-1 protects beta-cells against apoptosis by increasing the activity of an IGF-2/IGF-1 receptor autocrine loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Gut Commensal E. coli Proteins Activate Host Satiety Pathways following Nutrient-Induced Bacterial Growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Could the gut microbiota reconcile the oral bioavailability conundrum of traditional herbs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Green tea (-)-epigallocatechin-3-gallate reduces body weight with regulation of multiple genes expression in adipose tissue of diet-induced obese mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Effects of different doses of resveratrol on body fat and serum parameters in rats fed a hypercaloric diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Resveratrol in metabolic health: an overview of the current evidence and perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Therapeutic potential of resveratrol in obesity and type 2 diabetes: new avenues for health benefits?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Type of vegetarian diet, body weight, and prevalence of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Dietary flavonoid intake and weight maintenance: three prospective cohorts of 124,086 US men and women followed for up to 24 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

The effects of green tea on weight loss and weight maintenance: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

The use of green coffee extract as a weight loss supplement: a systematic review and meta-analysis of randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

The Use of Garcinia Extract (Hydroxycitric Acid) as a Weight loss Supplement: A Systematic Review and Meta-Analysis of Randomised Clinical Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Short-term supplementation with a specific combination of dietary polyphenols increases energy expenditure and alters substrate metabolism in overweight subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Deep sequencing of plant and animal DNA contained within traditional Chinese medicines reveals legality issues and health safety concerns

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Aristolochic acid-associated urothelial cancer in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Effect of Caralluma fimbriata extract on appetite, food intake and anthropometry in adult Indian men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Satiereal, a Crocus sativus L extract, reduces snacking and increases satiety in a randomized placebo-controlled study of mildly overweight, healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

A fenugreek seed extract selectively reduces spontaneous fat intake in overweight subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

The use of a Cissus quadrangularis/Irvingia gabonensis combination in the management of weight loss: a double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Effects of 15-d repeated consumption of Hoodia gordonii purified extract on safety, ad libitum energy intake, and body weight in healthy, overweight women: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

The efficacy of Phaseolus vulgaris as a weight-loss supplement: a systematic review and meta-analysis of randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Effects of novel capsinoid treatment on fatness and energy metabolism in humans: possible pharmacogenetic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Effects of dietary supplementation with epigallocatechin-3-gallate on weight loss, energy homeostasis, cardiometabolic risk factors and liver function in obese women: randomised, double-blind, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

The efficacy of glucomannan supplementation in overweight and obesity: a systematic review and meta-analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Eight weeks of supplementation with a multi-ingredient weight loss product enhances body composition, reduces hip and waist girth, and increases energy levels in overweight men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Effects of catechin enriched green tea on body composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

A green tea extract high in catechins reduces body fat and cardiovascular risks in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Improvements of mean body mass index and body weight in preobese and overweight Japanese adults with black Chinese tea (Pu-Erh) water extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Positive effect of mushrooms substituted for meat on body weight, body composition, and health parameters. A 1-year randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Limitations in anti-obesity drug development: the critical role of hunger-promoting neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Short-chain fatty acids in control of body weight and insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

A randomized double-blind placebo-controlled clinical trial of a product containing ephedrine, caffeine and other ingredients from herbal sources for treatment of overweight and obesity in the absence of lifestyle treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Mushroom as a potential source of prebiotics: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Obesity as a medical problem

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Genetics of human obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Surgical treatment of obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Overview of adrenergic anorectic agents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Berberine activates thermogenesis in white and brown adipose tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Beta cell dysfunction and insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Polyphenols: antioxidants and beyond

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Chitosan reduces plasma adipocytokines and lipid accumulation in liver and adipose tissues and ameliorates insulin resistance in diabetic rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Ameliorative effects of glycyrrhizin on streptozotocin-induced diabetes in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Obesity: Medicinal mushroom reduces obesity by modulating microbiota

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Serum lipid and blood pressure responses to quercetin vary in overweight patients by apolipoprotein E genotype

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.142

Common dietary supplements for weight loss.

31 March 2020

1 reference

12 December 2020

Soluble Fiber Polysaccharides: Effects on Plasma Cholesterol and Colonic Fermentation

1 reference

12 December 2020

FTY720 story. Its discovery and the following accelerated development of sphingosine 1-phosphate receptor agonists as immunomodulators based on reverse pharmacology

1 reference

12 December 2020

Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis

1 reference

12 December 2020

Plant-derived therapeutics for the treatment of metabolic syndrome

1 reference

12 December 2020

Greenselect Phytosome as an adjunct to a low-calorie diet for treatment of obesity: a clinical trial.

1 reference

12 December 2020

Mode of action of orlistat

1 reference

12 December 2020

Reduction of adipose tissue and body weight: effect of water soluble calcium hydroxycitrate in Garcinia atroviridis on the short term treatment of obese women in Thailand.

1 reference

12 December 2020

The obesity epidemic: challenges, health initiatives, and implications for gastroenterologists

1 reference

12 December 2020

Effect of a proprietary Magnolia and Phellodendron extract on weight management: a pilot, double-blind, placebo-controlled clinical trial.

1 reference

12 December 2020

Ephedra and its application to sport performance: another concern for the athletic trainer?

1 reference

12 December 2020

Physiological and metabolic effects of dietary fiber

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2016.142

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27636731%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27636731%20AND%20SRC:MED&resulttype=core&format=json